business
Merck Buys Sigma-Aldrich for $17B
Merck Buys Sigma-Aldrich for $17B
Kerry Grens | Sep 22, 2014
Two giants merge as the German drug maker acquires the US-based science supply company.
Keeping Up with IP
Keeping Up with IP
Kate Yandell | Sep 1, 2014
It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.
Roche Buys Biotech for $8.3B
Roche Buys Biotech for $8.3B
Jef Akst | Aug 27, 2014
The pharma giant strikes a deal to acquire InterMune, a Brisbane, California-based biotech with only one product—a treatment for a fatal lung disease.
Biotech Terminates IPO
Biotech Terminates IPO
Jyoti Madhusoodanan | Aug 15, 2014
The Israeli firm Vascular Biogenics withdrew its initial public offering after six days of trading. 
Scripps’s President Steps Down
Scripps’s President Steps Down
Kerry Grens | Jul 23, 2014
Following widespread disapproval among faculty members, Scripps’s Michael Marletta resigns his post.
AbbVie Buys Shire for $54 Billion
AbbVie Buys Shire for $54 Billion
Bob Grant | Jul 21, 2014
The massive pharma deal will create one of the 50 largest companies in the world, and will move AbbVie’s corporate tax headquarters from North Chicago to the U.K.
2014 Salary Survey Closed
2014 Salary Survey Closed
The Scientist Staff | Jul 14, 2014
Check back for the results in November!
Agencies Partner to Help Commercialize Biomedical Discoveries
Agencies Partner to Help Commercialize Biomedical Discoveries
Jyoti Madhusoodanan | Jun 19, 2014
Collaborative effort from the US National Science Foundation and National Institutes of Health offers business training for federally funded researchers.
Pharma Buyout Tabled
Pharma Buyout Tabled
Tracy Vence | May 27, 2014
Pfizer says it won’t continue its pursuit to purchase AstraZeneca—at least for now.
Novartis and Glaxo Agree to Big Deal
Novartis and Glaxo Agree to Big Deal
Bob Grant | Apr 22, 2014
The pharmaceutical companies announce a suite of asset swaps that drove up share prices and will reshape both.